News

Banner ASC in Sun City, Arizona.

A new study found cumulative radiation exposure of 16 mSv to red bone marrow can cause an increased rate of some hematological malignancies.

Several such IR procedures require US guidance, but a new study is questioning the modality’s effectiveness in reducing complication rates. 

Thumbnail

Three factors are associated with true high-risk findings—imaging protocols for aortic valve implantation planning, imaging area, and cardiology department orders.

AURORA trial results for Flurpiridaz F-18 PET vs. SPECT discussed by principal investigator Jamshid Maddahi, MD.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

breast cancer screening mammography

This information could help providers personalize breast cancer screening strategies and initiate treatment earlier.

Ultrafast/high frame rate myocardial contrast echocardiography

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Thumbnail

After reviewing years of data from its clinic, one institution discovered that issues with implant data integrity frequently put patients at risk. 

Thumbnail

A woman in New Zealand is now battling advanced cancer after signs of worsening prognosis eluded the eyes of a radiologist.  

Thumbnail

After reviewing years of data from its clinic, one institution discovered that issues with implant data integrity frequently put patients at risk. 

Thumbnail

A woman in New Zealand is now battling advanced cancer after signs of worsening prognosis eluded the eyes of a radiologist.  

mammogram mammography breast cancer

According to new survey data, nonadherence is not for lack of concern about the disease—75% of the women surveyed reported being concerned about their breast health.  

breast cancer month ribbon

This week, the American Cancer Society’s annual Breast Cancer Statistics report revealed several eye-opening figures.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.